StockData
Theriva Biologics, Inc. logo

Theriva Biologics, Inc. (TOVX) stock

TOVXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$0.14+0.00 (+2.86%)

Close on Nov 18, 2026Market cap $6.61MP/E –Yield –

Theriva Biologics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Theriva Biologics's market cap was $7.38M on Nov 11, 2026, against $2.78M a year earlier. Over the last 5 years it ranged from $1.21M to $38.29M, with a median of $8.05M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$7.38M+240.6%
2025Dec 31, 2025$2.17M-52.7%
2024Dec 31, 2024$4.58M-37.5%
2023Dec 29, 2023$7.33M+1.7%
2022Dec 30, 2022$7.21M-80.0%
2021Dec 31, 2021$35.94M+372.9%
2020Dec 31, 2020$7.60M-11.3%
2019Dec 31, 2019$8.57M+186.4%
2018Dec 31, 2018$2.99M-95.4%
2017Dec 29, 2017$65.57M-5.9%
2016Dec 30, 2016$69.66M-66.5%
2015Dec 31, 2015$207.95M+143.7%
2014Dec 31, 2014$85.34M+24.9%
2013Dec 31, 2013$68.32M+16.6%
2012Dec 31, 2012$58.61M+64.9%
2011Dec 30, 2011$35.54M–

More Theriva Biologics figures

See a number that looks wrong?